Cofinimmo: acquires two healthcare sites in Germany
PRESS RELEASE
Brussels, embargo until 01.07.2022, 5.40 p.m. CET
Cofinimmo acquires two healthcare sites in Germany
Cofinimmo (Euronext Brussels: COFB) has signed agreements to acquire, under certain conditions, two healthcare sites in Germany. The first asset is located in Schleswig-Holstein, the second in North Rhine-Westphalia. The investment for the two sites amounts to approximately 23 million EUR, property transfer taxes and works included. Both assets are currently in operation and managed by the Korian group.
House Curanum Liesborn – Wadersloh
Jean PierreHanin, CEO of Cofinimmo: “The acquisition of these two healthcare sites fits perfectly into our growth strategy in the German healthcare real estate sector. With the renovation of one of these sites, we are actively participating in the renewal and upgrading of the healthcare real estate portfolio in Germany.”
1
PRESS RELEASE
Brussels, embargo until 01.07.2022, 5.40 p.m. CET
1. Construction sites
Haus Curanum Liesborn is a nursing and care home located in Wadersloh, a municipality in North Rhine-Westphalia, the most densely populated state and the fourth largest in Germany. This asset is within walking distance of public transport and therefore easily accessible. It has an area of approximately 5,000 m², providing short-term or permanent care to 88 residents. It consists of three interconnected sections. Two spaces are specially adapted to the needs of people with dementia. The establishment was completely renovated between 2013 and 2015.
Seniorenresidenz Geertz is a health site located in Bad Schwartau, a municipality in Schleswig-Holstein, the northernmost German state with a population of around 3 million. The asset is only a few minutes walk from the city center and easily accessible by public transport (several bus stops within walking distance). Currently, it consists of a nursing and care home with 55 beds and 95 service apartments, spread over an area of around 10,600 m². Over the next two years, this asset will be renovated, including additional assisted living units and day care units.
2. The transaction |
Senior residence Geertz – Bad Schwartau |
The Cofinimmo group has signed, through a subsidiary, agreements to acquire, under certain conditions, these two healthcare sites in Germany. The investment for the two sites amounts to approximately 23 million EUR, property transfer taxes and works included. The conditions (mainly administrative) should be lifted in the third quarter of 2022.
This amount may be allocated to the hypothetical investment envelope included in the investment estimate for 2022, as published in section 11.1 of the press release of 29.04.2022.
For each site, a ‘Dach & Fach’1 lease agreement was signed for a firm term of 15 years with Korian, which already operates the sites. The rents will be indexed on the basis of the German consumer price index. The gross rental yield will be approximately 4.5%.
3. Operator
Korian is the leading European group providing care services for the elderly and frail. The group operates Europe’s leading network for long-term care, healthcare and community care. The group’s 60,000 employees provide care, services and support to more than 650,000 patients and residents in seven countries (France, Germany, Italy, Belgium, the Netherlands, Spain and the United Kingdom) within three families of activities : Addiction, Health and Community Care. In Germany, Korian ranks first in the field of rest and care homes, some of which include small specialized care units, establishments for people in a chronic vegetative state or units for the treatment of symptoms of dependence and addiction. . Nearly 23,000 employees care for around 44,000 residents in 259 facilities, spread throughout Germany.
1 The owner mainly bears the maintenance costs of the roof and the structure of the building.
2
PRESS RELEASE
Brussels, embargo until 01.07.2022, 5.40 p.m. CET
For more information: |
||
Philippe Etienne |
Lynn Nachtergaele |
Yeliz Bicici |
External Communication Manager |
Head of Investor Relations |
CEO |
Such. : +32 2 373 60 32 |
Such. : +32 2 777 14 08 |
Offices & Property Development |
|
|
Such. : +32 2 373 00 00 |
About Cofinimmo:
Cofinimmo has been acquiring, developing and managing rental properties for nearly 40 years. The company has a portfolio divided between Belgium, France, the Netherlands, Germany, Spain, Finland, Ireland, Italy and the United Kingdom worth approximately 5, 9 billion euros. Responding to societal changes, Cofinimmo’s mission is to offer partner-tenants quality care, living and working spaces for the greatest pleasure of their occupants. ‘Caring, Living and Working – Together in Real Estate’ is the expression of this mission. Thanks to its expertise, Cofinimmo has built up a healthcare real estate portfolio of around EUR 4.0 billion in Europe.
As an independent company applying the highest standards of corporate governance and sustainable development, Cofinimmo offers services to tenants and manages its portfolio thanks to a team of approximately 150 employees in Brussels, Paris, Breda, Frankfurt and Madrid. .
Cofinimmo is listed on Euronext Brussels (BEL20) and benefits from REIT status in Belgium (SIR), France (SIIC) and the Netherlands (FBI). Its activities are supervised by the Financial Services and Markets Authority (FSMA), the Belgian regulator.
As of 30.06.2022, the total market capitalization of Cofinimmo was approximately 3.3 billion EUR. The company applies an investment policy aimed at offering socially responsible, long-term, low-risk investment that generates regular, predictable and growing dividends.
www.cofinimmo.com
Follow us on:
3
Disclaimer
Cofinimmo SA published this content on July 01, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, on July 01, 2022 15:52:06 UTC.
Public now 2022
|
|
|
|
|
||||
COFINIMMO technical analysis trends
Short term | Middle term | Long term | |
Tendencies | Bearish | Bearish | Bearish |
Evolution of the income statement
Sale ![]() To buy |
|
Medium consensus | TO BUY |
Number of analysts | 11 |
Last closing price | €104.90 |
Average target price | €143.23 |
Average Spread / Target | 36.5% |
Comments are closed.